{"transactions":[{"id":678895,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-21T20:49:40.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001521111-26-000005","document":"form4-08212026_080836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/form4-08212026_080836.xml","form_type":"4"}},{"id":678894,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-08-21T20:49:40.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":7.0924,"value":709240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.02 to $7.21. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-26-000005","document":"form4-08212026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/form4-08212026_080836.xml","form_type":"4"}},{"id":678893,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-08-21T20:49:40.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.87,"value":187000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001521111-26-000005","document":"form4-08212026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/form4-08212026_080836.xml","form_type":"4"}},{"id":867962,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:57:16.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001521111-26-000003","document":"form4-03042026_120312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000003/form4-03042026_120312.xml","form_type":"4"}},{"id":990220,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990219,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":69051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years."}],"balance_after":229884,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":69051},"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990218,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":300000,"price":7.227,"value":2168100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990217,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":300000,"price":1.94,"value":582000.0,"ownership":{"direct":true},"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990216,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":69051,"price":7.227,"value":499031.577,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990215,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":69051,"price":1.74,"value":120148.74,"ownership":{"direct":true},"balance_after":69051,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":1012083,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-29T20:24:30.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years."}],"balance_after":298935,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001521111-25-000003","document":"form4-10292025_081026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000003/form4-10292025_081026.xml","form_type":"4"}},{"id":1012082,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-29T20:24:30.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":5.0246,"value":502460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-25-000003","document":"form4-10292025_081026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000003/form4-10292025_081026.xml","form_type":"4"}},{"id":1012081,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-29T20:24:30.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.74,"value":174000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001521111-25-000003","document":"form4-10292025_081026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000003/form4-10292025_081026.xml","form_type":"4"}},{"id":1229181,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T23:30:44.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.97,"expiration_date":"2035-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-25-006688","document":"form4-03042025_110338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925006688/form4-03042025_110338.xml","form_type":"4"}},{"id":1603435,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T21:33:32.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-24-006294","document":"form4-03042024_090331.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588924006294/form4-03042024_090331.xml","form_type":"4"}},{"id":1979866,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T22:56:00.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-014882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919123014882/doc4.xml","form_type":"4"}},{"id":2170029,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-31T21:16:20.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":400000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-22-048151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122048151/doc4.xml","form_type":"4"}},{"id":2361194,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T22:06:06.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":5.06,"expiration_date":"2032-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-22-014872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122014872/doc4.xml","form_type":"4"}},{"id":2863788,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T22:47:42.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":398935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\") and Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for an option to purchase 398,935 shares of Legacy Nuvation Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years."}],"balance_after":398935,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":398935},"source":{"system":"sec-edgar","filing":"0001209191-21-010334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010334/doc4.xml","form_type":"4"}},{"id":2863787,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T22:47:42.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":398935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\") and Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for an option to purchase 398,935 shares of Legacy Nuvation Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest as to 20% on October 5, 2023, 20% on October 5, 2023 and 60% on October 5, 2025, subject to achievement of performance criteria."}],"balance_after":398935,"derivative":{"exercise_price":4.6,"expiration_date":"2030-10-04","underlying":"Class A Common Stock","underlying_shares":398935},"source":{"system":"sec-edgar","filing":"0001209191-21-010334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010334/doc4.xml","form_type":"4"}},{"id":4054648,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-15T19:41:29.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 13, 2019 and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":60000,"derivative":{"exercise_price":37.83,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-010550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919118010550/doc4.xml","form_type":"4"}},{"id":4431348,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-22T16:27:29.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 17, 2018 and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":75000,"derivative":{"exercise_price":45.65,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-013258","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919117013258/doc4.xml","form_type":"4"}}]}